To test whether PGE2 impairs cDC1-mediated CD8+ T cell priming, we injected WT mice with PGE2-producing control or PGE2-deficient Ptgs1/Ptgs2−/− BRAFV600E melanoma cells engineered to express the model antigen ovalbumin (OVA). This evidence concerns the gene CD8A and melanoma.